Pseudomonas aeruginosa infection is a predominant cause of morbidity and mortality in
patients with cystic fibrosis infection and with a compromised immune system. Emergence of …

Rapidly growing antimicrobial resistance (AMR) against antibiotics has propelled the
development of synthetic antimicrobial peptides (AMPs) as potential antimicrobial agents …

Antibiotic resistance is an increasing public health concern around the world. Rapid
increase in the emergence of multidrug-resistant bacteria has been the target of extensive …

Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the
treatment of antibiotic-resistant bacterial infections. The present study investigates the …

Antimicrobial peptides (AMPs) hold promise to circumvent the emergence of drug resistance
occurring in the treatment of bacteria using many conventional antibiotics. Antimicrobial …

The World Health Organization has recently published a list of 12 drug-resistant bacteria that
posed a significant threat to human health, and Pseudomonas aeruginosa (P. aeruginosa) …

Antibiotic resistance is a serious health and social problem that will have a substantial
impact in the coming years on the world health and economy. Thus, the increasing demand …

Lung infection is the leading cause of morbidity and mortality in cystic fibrosis (CF) patients
and is mainly dominated by Pseudomonas aeruginosa. Treatment of CF-associated lung …

Resistant pathogenic microbial strains are emerging at a rate that far exceeds the pace of
new anti-infective drug development. In order to combat resistance development, there is …

With the rise of various multidrug-resistant (MDR) pathogenic bacteria, worldwide health
care is under pressure to respond. Conventional antibiotics are failing and the development …